Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $48.5100 (0.94%) ($48.5100 - $48.5100) on Fri. Jan. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.27% (three month average) | RSI | 35 | Latest Price | $48.5100(0.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.4% a day on average for past five trading days. | Weekly Trend | TGTX declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -3.135% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-3%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.135% (StdDev 6.27%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $41.31(-14.84%) | Resistance Level | $50.52 | 5 Day Moving Average | $48.62(-0.23%) | 10 Day Moving Average | $48.96(-0.92%) | 20 Day Moving Average | $50.52(-3.98%) | To recent high | -11.4% | To recent low | 92.3% | Market Cap | $6.144b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |